DK0684812T3 - Kondenseret-fase mikropartikel-præparat og fremgangsmåde - Google Patents

Kondenseret-fase mikropartikel-præparat og fremgangsmåde

Info

Publication number
DK0684812T3
DK0684812T3 DK94909762T DK94909762T DK0684812T3 DK 0684812 T3 DK0684812 T3 DK 0684812T3 DK 94909762 T DK94909762 T DK 94909762T DK 94909762 T DK94909762 T DK 94909762T DK 0684812 T3 DK0684812 T3 DK 0684812T3
Authority
DK
Denmark
Prior art keywords
condensed
microparticle preparation
phase microparticle
phase
disclosed
Prior art date
Application number
DK94909762T
Other languages
English (en)
Inventor
Julio M Fernandez
Mark B Knudson
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of DK0684812T3 publication Critical patent/DK0684812T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
DK94909762T 1993-02-12 1994-02-10 Kondenseret-fase mikropartikel-præparat og fremgangsmåde DK0684812T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1768193A 1993-02-12 1993-02-12
PCT/US1994/001924 WO1994017786A1 (en) 1993-02-12 1994-02-10 Condensed-phase microparticle composition and method

Publications (1)

Publication Number Publication Date
DK0684812T3 true DK0684812T3 (da) 1998-09-21

Family

ID=21783984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909762T DK0684812T3 (da) 1993-02-12 1994-02-10 Kondenseret-fase mikropartikel-præparat og fremgangsmåde

Country Status (9)

Country Link
EP (1) EP0684812B1 (da)
JP (1) JPH08509956A (da)
AT (1) ATE162397T1 (da)
AU (1) AU676543B2 (da)
CA (1) CA2155648C (da)
DE (1) DE69408122T2 (da)
DK (1) DK0684812T3 (da)
ES (1) ES2114184T3 (da)
WO (1) WO1994017786A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
GB9320668D0 (en) 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
WO1996000295A1 (en) 1994-06-27 1996-01-04 The Johns Hopkins University Targeted gene delivery system
AU3739697A (en) * 1996-07-09 1998-02-02 Johns Hopkins University, The Gene delivery system
JP4335316B2 (ja) * 1996-09-19 2009-09-30 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー
CA2319437C (en) 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US5952232A (en) * 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
DE19943429A1 (de) * 1999-09-08 2001-03-15 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an sulfonierten Kammpolymeren
US8246945B2 (en) 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
EP1272213B1 (en) 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbial delivery system
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7056535B2 (en) 2001-12-20 2006-06-06 Kimberly-Clark Worldwide, Inc. Triggered release from proteinoid microspheres
US20030138975A1 (en) * 2001-12-20 2003-07-24 Kimberly-Clark Worldwide, Inc. Diagnostic signal amplification with proteinoid microspheres

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI84874C (fi) * 1989-11-02 1992-02-10 Valio Meijerien Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den.
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
FR2677249B1 (fr) * 1991-06-04 1995-03-17 Biovecteurs As Vecteur particulaire biodegradable et procede de synthese.

Also Published As

Publication number Publication date
JPH08509956A (ja) 1996-10-22
EP0684812A1 (en) 1995-12-06
CA2155648C (en) 1999-05-11
AU6247994A (en) 1994-08-29
DE69408122T2 (de) 1998-09-03
EP0684812B1 (en) 1998-01-21
ES2114184T3 (es) 1998-05-16
ATE162397T1 (de) 1998-02-15
AU676543B2 (en) 1997-03-13
WO1994017786A1 (en) 1994-08-18
DE69408122D1 (de) 1998-02-26
CA2155648A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
DK0696921T3 (da) Veterinært præparat indeholdende en protonpumpeinhibitor
DE69735581D1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
AU6819294A (en) Oral drug delivery compositions and methods
ATE545652T1 (de) Reinigung und stabilisierung von proteinen und peptiden in pharmaceutischen agentien
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
ATE162397T1 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
NZ320237A (en) Stable pharmaceutical forms of administration containing parathormone
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
NO962655L (no) Deutrerte virkestoffer i transdermal applikasjon
ES2036526T3 (es) Composiciones de interferon.
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
DE59604491D1 (de) Polymerisierbare aromatische carbonsäuren und carbonsäureanhydride mit cyclischen carbonatgruppen sowie zubereitungen, enthaltend diese verbindungen
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
KR900017599A (ko) 종양 치료용 약학 조성물
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
UA49572A (uk) Спосіб лікування затяжних пневмоній
UA30787A (uk) Спосіб лікування хронічного персистуючого гепатиту
UA30911A (uk) Спосіб поліхіміотерапії хворих деструктивним туберкульозом легень